Yipinhong Pharmaceutical Co Ltd Class A (300723) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥14.81 Million ≈ $2.17 Million USD) by net assets (CN¥1.80 Billion ≈ $263.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yipinhong Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300723 liabilities breakdown for a breakdown of total debt and financial obligations.

Yipinhong Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tianma Microelectronics Co Ltd SHE:000050	0.018x
Zhuzhou Kibing Group Co Ltd SHG:601636	0.050x
Jiangsu Lopal Tech Co Ltd SHG:603906	-0.012x
Supernus Pharmaceuticals Inc NASDAQ:SUPN	-0.059x
Piramal Enterprises Limited NSE:PEL	-0.299x
Zibo Qixiang Tengda Chemical Co Ltd SHE:002408	0.009x
Exxaro Resources Ltd JSE:EXX	0.081x
Boralex Inc TO:BLX	0.019x

Annual Cash Flow Conversion Efficiency for Yipinhong Pharmaceutical Co Ltd Class A (2013–2024)

The table below shows the annual cash flow conversion efficiency of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Yipinhong Pharmaceutical Co Ltd Class A market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.94 Billion ≈ $283.28 Million	CN¥-550.42 Million ≈ $-80.54 Million	-0.284x	-261.26%
2023-12-31	CN¥2.60 Billion ≈ $380.16 Million	CN¥458.05 Million ≈ $67.03 Million	0.176x	-19.70%
2022-12-31	CN¥2.17 Billion ≈ $316.92 Million	CN¥475.53 Million ≈ $69.59 Million	0.220x	+1.16%
2021-12-31	CN¥2.02 Billion ≈ $295.35 Million	CN¥438.10 Million ≈ $64.11 Million	0.217x	+17.91%
2020-12-31	CN¥1.50 Billion ≈ $218.77 Million	CN¥275.22 Million ≈ $40.27 Million	0.184x	-12.06%
2019-12-31	CN¥1.34 Billion ≈ $196.17 Million	CN¥280.65 Million ≈ $41.07 Million	0.209x	+14.00%
2018-12-31	CN¥1.30 Billion ≈ $190.13 Million	CN¥238.60 Million ≈ $34.91 Million	0.184x	+44.01%
2017-12-31	CN¥1.11 Billion ≈ $162.20 Million	CN¥141.35 Million ≈ $20.68 Million	0.128x	-70.61%
2016-12-31	CN¥336.50 Million ≈ $49.24 Million	CN¥146.01 Million ≈ $21.37 Million	0.434x	+152.00%
2015-12-31	CN¥200.66 Million ≈ $29.36 Million	CN¥34.55 Million ≈ $5.06 Million	0.172x	+151.17%
2014-12-31	CN¥127.52 Million ≈ $18.66 Million	CN¥8.74 Million ≈ $1.28 Million	0.069x	-90.62%
2013-12-31	CN¥185.61 Million ≈ $27.16 Million	CN¥135.68 Million ≈ $19.85 Million	0.731x	--

About Yipinhong Pharmaceutical Co Ltd Class A

SHE:300723 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.74 Billion

CN¥18.72 Billion CNY

Market Cap Rank

#5209 Global

#1027 in China

Share Price

CN¥41.45

Change (1 day)

+4.09%

52-Week Range

CN¥29.56 - CN¥80.53

All Time High

CN¥80.53